- Report
- February 2024
- 250 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- February 2024
- 250 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- February 2024
- 250 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- February 2024
- 250 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- February 2023
- 250 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- November 2023
- 130 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- November 2023
- 180 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- May 2023
- 160 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- February 2024
- 260 Pages
Global
From €2338EUR$2,450USD£1,959GBP
- Report
- January 2022
- 194 Pages
Global
From €2100EUR$2,200USD£1,759GBP
- Report
- July 2024
- 80 Pages
Japan
From €3340EUR$3,500USD£2,799GBP
- Report
- April 2024
- 88 Pages
France
From €3340EUR$3,500USD£2,799GBP
- Report
- July 2023
- 78 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- March 2024
- 87 Pages
From €3293EUR$3,450USD£2,759GBP
- Report
- February 2024
- 180 Pages
Global
From €4247EUR$4,450USD£3,558GBP
- Report
- March 2023
- 346 Pages
Global
From €4247EUR$4,450USD£3,558GBP
- Report
- January 2022
- 181 Pages
Global
From €4247EUR$4,450USD£3,558GBP
- Report
- October 2021
- 157 Pages
Global
From €4247EUR$4,450USD£3,558GBP
- Report
- November 2023
- 122 Pages
Asia Pacific
From €3818EUR$4,000USD£3,199GBP
- Report
- December 2022
- 142 Pages
Global
From €4247EUR$4,450USD£3,558GBP

The Antibody Drug market is a subset of the biotechnology industry that focuses on the development and commercialization of therapeutic antibodies. Antibody drugs are used to treat a variety of diseases, including cancer, autoimmune diseases, and infectious diseases. These drugs are designed to target specific molecules in the body, such as proteins, hormones, and enzymes, and can be used to block or activate certain pathways. Antibody drugs are typically administered intravenously or subcutaneously, and can be used in combination with other drugs or therapies.
The Antibody Drug market is highly competitive, with many companies investing in research and development to create new and improved treatments. Companies in the market are focused on developing novel antibodies, as well as improving existing treatments. Additionally, companies are investing in the development of biosimilars, which are generic versions of existing antibody drugs.
Some companies in the Antibody Drug market include AbbVie, Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, Eli Lilly, Genentech, GlaxoSmithKline, Merck, Novartis, Pfizer, Regeneron, Roche, and Sanofi. Show Less Read more